bupivacaine

1
Reactions 1252 - 16 May 2009 S Bupivacaine Cardiotoxicity following accidental intravascular administration: case report A 33-year-old man developed cardiotoxicity following accidental intravascular injection of bupivacaine during performance of a brachial block for surgery. The man presented for debridement of a compound fracture of the humerus. Following a single-injection infraclavicular paracoracoid block using 0.375% bupivacaine 30mL, given over 3 minutes with aspiration at 5mL intervals, he abruptly reported the onset of a dry sensation in his eyes and throat. The injection was immediately stopped. The man immediately developed seizures and apnoea, and ventilatory support was started. He received soya oil emulsion within 30 seconds of seizure onset and the seizures stopped after thiopental sodium was given. An ECG trace then showed a narrow complex tachycardia which peaked at 160 beats/minute. Over 90 seconds, the tachycardia was followed by a broadening of QRS complexes, slowing of the heart, and asystole. He underwent cardiopulmonary resuscitation and tracheal intubation, and received epinephrine [adrenaline]. Over the 30 minutes following return of spontaneous circulation, further soya oil emulsion was infused and his heart rate and rhythm reverted to sinus tachycardia (110 beats/minute). Circulation was supported with an epinephrine infusion. He remained haemodynamically stable so it was decided to proceed with surgery. After surgery, and approximately 40 minutes following completion of the soya oil emulsion infusion, a progressively accelerating sinus tachycardia (140 beats/minute), accompanied by frequent multifocal ventricular extrasystoles and short, self-terminating runs of ventricular tachycardia were observed. This was presumed to be the recurrence of bupivacaine cardiotoxicity. No further soya oil emulsion was available, so he received amiodarone and was subsequently admitted to the ICU. His arrhythmias stopped and inotropic support was discontinued. On the first postarrest day, total creatine kinase of 2378 IU/L, MB fraction 26 µg/L and troponin I of 1.255 µg/L suggested that he had experienced myocardial damage. Four days later, his cardiac enzymes had decreased and he was discharged [patient outcome not stated]. Author comment: "[W]e report a case of recurrent systemic local anesthetic toxicity after successful treatment with lipid emulsion". Marwick PC, et al. Recurrence of cardiotoxicity after lipid rescue from bupivacaine-induced cardiac arrest. Anesthesia and Analgesia 108: 1344-1346, No. 4, Apr 2009 - South Africa 801141351 1 Reactions 16 May 2009 No. 1252 0114-9954/10/1252-0001/$14.95 © 2010 Adis Data Information BV. All rights reserved

Upload: lamnga

Post on 16-Mar-2017

215 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Bupivacaine

Reactions 1252 - 16 May 2009

SBupivacaine

Cardiotoxicity following accidental intravascularadministration: case report

A 33-year-old man developed cardiotoxicity followingaccidental intravascular injection of bupivacaine duringperformance of a brachial block for surgery.

The man presented for debridement of a compoundfracture of the humerus. Following a single-injectioninfraclavicular paracoracoid block using 0.375%bupivacaine 30mL, given over 3 minutes with aspiration at5mL intervals, he abruptly reported the onset of a drysensation in his eyes and throat.

The injection was immediately stopped. The manimmediately developed seizures and apnoea, andventilatory support was started. He received soya oilemulsion within 30 seconds of seizure onset and theseizures stopped after thiopental sodium was given. AnECG trace then showed a narrow complex tachycardiawhich peaked at 160 beats/minute. Over 90 seconds, thetachycardia was followed by a broadening of QRScomplexes, slowing of the heart, and asystole. Heunderwent cardiopulmonary resuscitation and trachealintubation, and received epinephrine [adrenaline]. Overthe 30 minutes following return of spontaneous circulation,further soya oil emulsion was infused and his heart rate andrhythm reverted to sinus tachycardia (110 beats/minute).Circulation was supported with an epinephrine infusion.He remained haemodynamically stable so it was decided toproceed with surgery. After surgery, and approximately40 minutes following completion of the soya oil emulsioninfusion, a progressively accelerating sinus tachycardia(140 beats/minute), accompanied by frequent multifocalventricular extrasystoles and short, self-terminating runs ofventricular tachycardia were observed. This was presumedto be the recurrence of bupivacaine cardiotoxicity. Nofurther soya oil emulsion was available, so he receivedamiodarone and was subsequently admitted to the ICU.His arrhythmias stopped and inotropic support wasdiscontinued. On the first postarrest day, total creatinekinase of 2378 IU/L, MB fraction 26 µg/L and troponin I of1.255 µg/L suggested that he had experienced myocardialdamage. Four days later, his cardiac enzymes haddecreased and he was discharged [patient outcome notstated].

Author comment: "[W]e report a case of recurrentsystemic local anesthetic toxicity after successful treatmentwith lipid emulsion".Marwick PC, et al. Recurrence of cardiotoxicity after lipid rescue frombupivacaine-induced cardiac arrest. Anesthesia and Analgesia 108: 1344-1346, No.4, Apr 2009 - South Africa 801141351

1

Reactions 16 May 2009 No. 12520114-9954/10/1252-0001/$14.95 © 2010 Adis Data Information BV. All rights reserved